Turn Therapeutics Inc.
TTRX • Biotechnology
$10.47
▼ -0.27 (-2.51%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 54%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$308.61M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.02Weak liquidity · 0.87Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 11, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:15 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$10.47
Change-2.51%
Shares Out29.48M
Market Cap$308.61M
Enterprise Value$303.38M
52W Range2.57 - 26.50
Beta2.10
P/E-80.44
P/B50.45
P/FCF-75.96
EV/EBITDA-45.43
EV/FCF-74.67
Price$10.47
Change-2.51%
Shares Out29.48M
Market Cap$308.61M
Enterprise Value$303.38M
52W Range2.57 - 26.50
Beta2.10
P/E-80.44
P/B50.45
P/FCF-75.96
EV/EBITDA-45.43
EV/FCF-74.67
Earnings Yield-1.24%
FCF Yield-1.32%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.02
Current Ratio0.87
Quick Ratio0.87
Volume63.75K
Avg Volume64.45K
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
26
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
49/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Manageable debt level · 0.02Weak liquidity · 0.87Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-10-21
50/100
Neutral
Bullish
1
Hold
0
Bearish
1
🧾
No insider activity
No recent insider transactions available.